Wendi Malley

Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease Activity

J. Greenberg, L. Harrold, D. Collier, 2018, The Journal of Rheumatology.

Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry

J. Greenberg, L. Harrold, D. Collier, 2017, Clinical Rheumatology.

Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas’ Psoriasis Registry

T. Fitzgerald, J. Walsh, J. Merola, 2021, Dermatology and Therapy.